| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.03 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |